Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant.

Faraci M, Diesch T, Labopin M, Dalissier A, Lankester A, Gennery A, Sundin M, Uckan-Cetinkaya D, Bierings M, Peters AMJ, Garwer M, Schulz A, Michel G, Giorgiani G, Gruhn B, Locatelli F, Giardino S, Uyttebroeck A, Rialland F, Itäla-Remes M, Dreger P, Shaw PJ, Bordon V, Schlegel PG, Mellgren K, Moraleda JM, Patrick K, Schneider P, Jubert C, Lawitschka A, Salooja N, Basak GW, Corbacioglu S, Duarte R, Bader P; Pediatric and Transplant Complications Working Parties of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2019 May 11. pii: S1083-8791(19)30289-7. doi: 10.1016/j.bbmt.2019.05.005. [Epub ahead of print]

PMID:
31082473
2.

Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution.

Bouazzaoui A, Dickhöfer S, Kreuz M, Huber E, Holler E, Wolff D.

Immunopharmacol Immunotoxicol. 2014 Apr;36(2):158-64. doi: 10.3109/08923973.2014.895743. Epub 2014 Mar 4.

PMID:
24588615
3.

Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.

Choudhary D, Sharma SK, Gupta N, Kharya G, Pavecha P, Handoo A, Setia R, Katewa S.

Biol Blood Marrow Transplant. 2013 Mar;19(3):492-5. doi: 10.1016/j.bbmt.2012.11.007. Epub 2012 Nov 15.

4.

Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis.

Sheth V, Labopin M, Canaani J, Volin L, Brecht A, Ganser A, Mayer J, Labussière-Wallet H, Bittenbring J, Shouval R, Savani B, Mohty M, Nagler A.

Bone Marrow Transplant. 2019 Apr;54(4):531-539. doi: 10.1038/s41409-018-0288-0. Epub 2018 Aug 7.

PMID:
30087463
5.

Bone marrow transplantation for non-malignant diseases using treosulfan-based conditioning.

Dinur-Schejter Y, Krauss AC, Erlich O, Gorelik N, Yahel A, Porat I, Weintraub M, Stein J, Zaidman I, Stepensky P.

Pediatr Blood Cancer. 2015 Feb;62(2):299-304. doi: 10.1002/pbc.25267. Epub 2014 Oct 4.

PMID:
25284797
6.

Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT.

Główka F, Kasprzyk A, Romański M, Wróbel T, Wachowiak J, Szpecht D, Kałwak K, Wiela-Hojeńska A, Dziatkiewicz P, Teżyk A, Żaba C.

Eur J Pharm Sci. 2015 Feb 20;68:87-93. doi: 10.1016/j.ejps.2014.12.010. Epub 2014 Dec 16.

PMID:
25527118
7.

Disposition of treosulfan and its active monoepoxide in a bone marrow, liver, lungs, brain, and muscle: Studies in a rat model with clinical relevance.

Romański M, Kasprzyk A, Walczak M, Ziółkowska A, Główka F.

Eur J Pharm Sci. 2017 Nov 15;109:616-623. doi: 10.1016/j.ejps.2017.09.011. Epub 2017 Sep 12.

PMID:
28916482
8.

Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.

Danielak D, Twardosz J, Kasprzyk A, Wachowiak J, Kałwak K, Główka F.

Eur J Clin Pharmacol. 2018 Jan;74(1):79-89. doi: 10.1007/s00228-017-2344-x. Epub 2017 Oct 3.

9.

Relationship between exposure to treosulfan and its monoepoxytransformer - An insight from population pharmacokinetic study in pediatric patients before hematopoietic stem cell transplantation.

Danielak D, Kasprzyk A, Wróbel T, Wachowiak J, Kałwak K, Główka F.

Eur J Pharm Sci. 2018 Jul 30;120:1-9. doi: 10.1016/j.ejps.2018.04.036. Epub 2018 Apr 27.

PMID:
29705215
10.

European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.

Boztug H, Sykora KW, Slatter M, Zecca M, Veys P, Lankester A, Cant A, Skinner R, Wachowiak J, Glogova E, Pötschger U, Peters C.

Pediatr Blood Cancer. 2016 Jan;63(1):139-48. doi: 10.1002/pbc.25764. Epub 2015 Sep 23.

PMID:
26398915
11.

Treosulfan induces distinctive gonadal toxicity compared with busulfan.

Levi M, Stemmer SM, Stein J, Shalgi R, Ben-Aharon I.

Oncotarget. 2018 Apr 10;9(27):19317-19327. doi: 10.18632/oncotarget.25029. eCollection 2018 Apr 10.

12.

Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.

Vatanen A, Wilhelmsson M, Borgström B, Gustafsson B, Taskinen M, Saarinen-Pihkala UM, Winiarski J, Jahnukainen K.

Eur J Endocrinol. 2013 Dec 27;170(2):211-8. doi: 10.1530/EJE-13-0694. Print 2014 Feb.

PMID:
24179099
13.

Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party.

Wachowiak J, Sykora KW, Cornish J, Chybicka A, Kowalczyk JR, Gorczyńska E, Choma M, Grund G, Peters C; EBMT Pediatric Diseases Working Party.

Bone Marrow Transplant. 2011 Dec;46(12):1510-8. doi: 10.1038/bmt.2010.343. Epub 2011 Feb 7.

PMID:
21297673
15.

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.

Michel G, Socié G, Gebhard F, Bernaudin F, Thuret I, Vannier JP, Demeocq F, Leverger G, Pico JL, Rubie H, Mechinaud F, Reiffers J, Gratecos N, Troussard X, Jouet JP, Simonin G, Gluckman E, Maraninchi D.

J Clin Oncol. 1997 Jun;15(6):2238-46.

PMID:
9196136
16.

Second Hematopoietic Stem Cell Transplant for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan-Based Conditioning Regimen.

Korula A, Pn N, Devasia A, Lakshmi KM, Abraham A, Sindhuvi E, George B, Srivastava A, Mathews V.

Biol Blood Marrow Transplant. 2018 Jan;24(1):103-108. doi: 10.1016/j.bbmt.2017.10.012. Epub 2017 Oct 12.

17.

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.

Shimoni A, Labopin M, Savani B, Hamladji RM, Beelen D, Mufti G, Socié G, Delage J, Blaise D, Chevallier P, Forcade E, Deconinck E, Mohty M, Nagler A.

Biol Blood Marrow Transplant. 2018 Apr;24(4):751-757. doi: 10.1016/j.bbmt.2017.12.776. Epub 2017 Dec 13.

18.

Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.

Mitsuhashi K, Kako S, Shigematsu A, Atsuta Y, Doki N, Fukuda T, Kanamori H, Onizuka M, Takahashi S, Ozawa Y, Kurokawa M, Inoue Y, Nagamura-Inoue T, Morishima Y, Mizuta S, Tanaka J; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2194-2200. doi: 10.1016/j.bbmt.2016.09.007. Epub 2016 Sep 13.

19.

Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Mohanan E, Panetta JC, Lakshmi KM, Edison ES, Korula A, Na F, Abraham A, Viswabandya A, George B, Mathews V, Srivastava A, Balasubramanian P.

Clin Pharmacol Ther. 2018 Sep;104(3):575-583. doi: 10.1002/cpt.988. Epub 2018 Jan 17.

20.

Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.

Ishida H, Kato M, Kudo K, Taga T, Tomizawa D, Miyamura T, Goto H, Inagaki J, Koh K, Terui K, Ogawa A, Kawano Y, Inoue M, Sawada A, Kato K, Atsuta Y, Yamashita T, Adachi S.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2141-2147. doi: 10.1016/j.bbmt.2015.08.011. Epub 2015 Aug 10.

Supplemental Content

Support Center